跳至主要内容
临床试验/IRCT20170530034232N2
IRCT20170530034232N2招募中4 期

Comparing the outcomes of Warfarin consumption compared to Rivaroxaban (Xalerban) in patients with Atrial fibrillation

Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences0 个研究点目标入组 330 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
All

入选标准

  • Being over 50 years old
  • Patients with Atrial fibrillation
  • CHAD2S2 Vasc Score more than 1

排除标准

  • Patient's dissatisfaction with the study
  • Wolff Parkinson White Syndrome
  • Allergic to any of the drugs Rivaroxaban (Xalerban) and warfarin
  • Abnormal Creatinine level
  • Thrombocytopenia

研究者

发起方
Vice-Chancellor For Research and Technology of Guilan University of Medical Sciences

相似试验